Changes of urinary alpha 1-microglobulin in the assessment of prognosis inrenal transplant recipients

Citation
Am. Teppo et al., Changes of urinary alpha 1-microglobulin in the assessment of prognosis inrenal transplant recipients, TRANSPLANT, 70(8), 2000, pp. 1154-1159
Citations number
39
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
70
Issue
8
Year of publication
2000
Pages
1154 - 1159
Database
ISI
SICI code
0041-1337(20001027)70:8<1154:COUA1I>2.0.ZU;2-0
Abstract
Background. After transplantation, even if the graft starts functioning imm ediately, there are morphological and functional changes in tubular structu res. In addition, acute allograft rejection causes damage in the tubular ep ithelium, tubular basement membrane, and intertubular connective tissue. It also affects the functional capacity of proximal tubular cells resulting i n impaired reabsorption and thus increased urinary excretion of low molecul ar weight proteins, Methods. We present a double-antibody radioimmunoassay for determination of the concentration of alpha1-microglobulin (alpha1 M) in urine. It was used to measure urinary excretion of alpha1 RI approximately once a week during the first 1-6 posttransplant weeks in 136 consecutive patients: 30 patient s developing acute rejection (75 24-hr urine samples) and 106 patients with stable graft function (223 24-hr urine samples), The results are expressed as alpha1 M/creatinine ratios. Results. Approximately 8 days after transplantation the mean (+/-SD) urinar y alpha1 M/creatinine ratio of all patients was 17,0+/-14.8 mg/mmol, being about the same both in patients with uncomplicated posttransplantation cour se (16.3+/-14.0 mg/mmol) and in those who later developed rejection (19.3+/ -15.1 mg/mmol), but about 60-fold higher than in healthy controls (0.27+/-0 .15 mg/mmol). At that time, when all patients were included there was a cor relation (r=0,3465, P<0.001) between <alpha>1 M/creatinine ratio and durati on of cold ischemia, Thereafter, during the second week alpha1 M/creatinine ratio decreased in 89% of patients with stable graft function, but only in 14% of patients who later developed rejection (P<0.001), On the contrary, a significant increase (P<0,01) of alpha1 M/creatinine ratio was observed 4 to 1 day before rejection in all 15 patients, who had urines collected at that time. At the end of the follow-up period, alpha1 M/creatinine ratio in patients with rejection was 3-fold compared with the nonrejecting patients , and 100-fold compared with the healthy controls. Conclusion. These results show that cadaveric transplantation results in im paired low molecular weight protein reabsorption, the degree of dysfunction relating to the duration of cold ischemia, and suggest that during the pos ttransplant weeks decreasing alpha1 M/creatinine ratio in consecutively col lected urine samples indicates improved tubular function and in most cases rules out development of acute rejection.